Cheaper EpiPen Alternative Symjepi Gets FDA Approval

Epipen has a new rival. A low-cost alternative to Mylan’s epinephrine autoinjector has been approved. Adamis Pharmaceuticals Corp.’s Symjepi will be sold at less than the price of generic EpiPens.
Tech Times : Top News

Play
Slider